Biosergen appoints Mangold Fondkommission to act as a liquidity provider
Biosergen AB (publ) (“Biosergen” or the “Company”) has appointed Mangold Fondkommission to act as a liquidity provider for the company's share. The liquidity providing will begin on Wednesday, October 5th, 2022.
Mangold Fondkommission will fulfil its mandate as a liquidity provider to continuously place trading posts on each buy and sell side in the Biosergen share booklet and ensure that a predetermined spread is held in the share. The purpose of the liquidity providing is to promote good liquidity and ensure a low spread between buy and sell prices in current trading.
